title: Treatment of aortic graft infection by in situ reconstruction with Omniflow II biosynthetic prosthesis.
abstract: Currently available conduits for in situ reconstruction after excision of infected aortic grafts have significant limitations. The Omniflow II vascular prosthesis is a biosynthetic graft associated with a low incidence of infection that has succesfully been used in the treatment of infected infrainguinal bypass. We report on the first use of the Omniflow II prosthesis for in situ reconstruction after aortic graft infection.A bifurcated biosynthetic bypass was created by spatulating and anastomosing two 8-mm tubular Omniflow II grafts. This bypass was used for in situ reconstruction after excision of infected aortic grafts in three cases. After a mean follow-up of 2.2 years, no occlusion, degeneration, or rupture of the Omniflow II grafts was observed. Although one patient suffered from graft reinfection, the bypass retained structural integrity and no anastomotic dehiscence was observed.Treatment of aortic graft infection by in situ reconstruction with the Omniflow II vascular prosthesis is feasible. Its resistance to infection and off-the-shelf availability make this graft a promising conduit for aortoiliac reconstruction.
authors.affiliation: Department of Surgery, Atrium Medical Center, Heerlen, the Netherlands.
authors.forename: A G
authors.initials: AG
authors.lastname: Krasznai
authors.affiliation: Department of Surgery, Atrium Medical Center, Heerlen, the Netherlands m.snoeijs@gmail.com.
authors.forename: Mgj
authors.initials: M
authors.lastname: Snoeijs
authors.affiliation: Department of Surgery, Atrium Medical Center, Heerlen, the Netherlands.
authors.forename: M P
authors.initials: MP
authors.lastname: Siroen
authors.affiliation: Department of Surgery, Atrium Medical Center, Heerlen, the Netherlands.
authors.forename: T
authors.initials: T
authors.lastname: Sigterman
authors.affiliation: Department of Nuclear Medicine, Atrium Medical Center, Heerlen, the Netherlands.
authors.forename: A
authors.initials: A
authors.lastname: Korsten
authors.affiliation: Department of Surgery, University Medical Center Utrecht, Utrecht, the Netherlands.
authors.forename: F L
authors.initials: FL
authors.lastname: Moll
authors.affiliation: Department of Surgery, Atrium Medical Center, Heerlen, the Netherlands.
authors.forename: L H
authors.initials: LH
authors.lastname: Bouwman
mesh_terms: D000368:Aged; D001011:Aorta / Q000000981:diagnostic imaging / Q000601:surgery*; D001807:Blood Vessel Prosthesis / Q000009:adverse effects*; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects* / Q000295:instrumentation*; D020878:Device Removal; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000072078:Positron Emission Tomography Computed Tomography; D011474:Prosthesis Design; D016459:Prosthesis-Related Infections / Q000000981:diagnostic imaging / Q000382:microbiology / Q000601:surgery*; D012008:Recurrence; D012086:Reoperation; D013997:Time Factors; D016896:Treatment Outcome
keywords: Graft infection; aortic surgery; vascular prosthesis